Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy-Reference-Cited by-同舟云学术

Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy

Published:2011-01-27 Issue:1 Volume:9 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Soong Ruey-Shyang,Yu Ming-Chin,Chan Kun-Ming,Chou Hong-Shiue,Wu Ting-Jung,Lee Chen-Fang,Wu Tsung-Han,Lee Wei-Chen

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1186/1477-7819-9-9.pdf

Reference22 articles.

1. Chuang SC, La Vecchia C, Boffetta P: Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Letters. 2009, 286: 9-14. 10.1016/j.canlet.2008.10.040.

2. Hasegawa K, Kokudo N: Surgical treatment of hepatocellular carcinoma. Surgery Today. 2009, 39: 833-843. 10.1007/s00595-008-4024-z.

3. Park YK, Kim BW, Wang HJ, Kim MW: Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transplantation Proceedings. 2009, 41: 1691-1697. 10.1016/j.transproceed.2008.07.146.

4. Yao FY: Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. American Journal of Transplantation. 2008, 8: 1982-1989. 10.1111/j.1600-6143.2008.02351.x.

5. Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR: Surgical management of hepatocellular carcinoma: is the jury still out?. Surgical Oncology. 2009, 18: 298-321. 10.1016/j.suronc.2008.08.003.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights;Journal of Hepatocellular Carcinoma;2022-09

2. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis;European Radiology;2022-05-17

3. Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma;Clinical Cancer Research;2020-07-07

4. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis;Journal of International Medical Research;2018-11-05

5. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells;Oncotarget;2016-06-20